[Anti-arrhythmia properties of the novel combined preparation based on sufan and possible mechanism of their realization].
Khankoeva
A I
AI
Dukhanin
A S
AS
Leonidov
N B
NB
Galenko-Iaroshevskiĭ
P A
PA
Galygo
D S
DS
D000818:Animals; D000889:Anti-Arrhythmia Agents / Q000008:administration & dosage / Q000494:pharmacology*; D001145:Arrhythmias, Cardiac / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control*; D001157:Arterial Occlusive Diseases / Q000150:complications / Q000503:physiopathology; D001565:Benzoates / Q000009:adverse effects / Q000494:pharmacology*; D002118:Calcium / Q000378:metabolism; D002415:Cats; D015687:Cell Hypoxia; D004357:Drug Synergism; D066298:In Vitro Techniques; D015428:Myocardial Reperfusion Injury / Q000150:complications / Q000503:physiopathology / Q000517:prevention & control; D009206:Myocardium / Q000166:cytology / Q000378:metabolism; D026941:Sodium Channel Blockers; D013386:Succinates / Q000008:administration & dosage / Q000494:pharmacology*; D014364:Tryptophan / Q000008:administration & dosage / Q000031:analogs & derivatives* / Q000494:pharmacology; D014693:Ventricular Fibrillation / Q000209:etiology / Q000503:physiopathology / Q000517:prevention & control
D000889:Anti-Arrhythmia Agents; D001565:Benzoates; D026941:Sodium Channel Blockers; D013386:Succinates; C111552:dimethylaminoethyl p-butylaminobenzoate; C107888:sufan; D014364:Tryptophan; D002118:Calcium
Antiaritmicheskie svoĭstva novogo kombinirovannogo preparata na osnove sufana i vozmozhnyĭ mekhanizm ikh realizatsii.